Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer

New insights into tumor immunity revealed by the unique genetic and genomic aspects of ovarian cancer

(2015) Brad H Nelson   CURRENT OPINION IN IMMUNOLOGY

Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis

(2015) Jo Marie Tran Janco et al.   JOURNAL OF IMMUNOLOGY

Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody

(2014) L. Karyampudi et al.   CANCER RESEARCH

Large-Scale Evaluation of Common Variation in Regulatory T Cell-Related Genes and Ovarian Cancer Outcome

(2014) B. Charbonneau et al.   Cancer Immunology Research

Expression of the Homeobox Gene HOXA9 in Ovarian Cancer Induces Peritoneal Macrophages to Acquire an M2 Tumor-Promoting Phenotype

(2013) Song Yi Ko et al.   AMERICAN JOURNAL OF PATHOLOGY

The Immune System in the Pathogenesis of Ovarian Cancer

(2013) Bridget Charbonneau et al.   CRITICAL REVIEWS IN IMMUNOLOGY

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

(2013) Paul D P Pharoah et al.   NATURE GENETICS

Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer

(2013) Ellen L. Goode et al.   PLoS One

The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer

(2013) Claudia C. Preston et al.   PLoS One

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

(2013) Jennifer Permuth-Wey et al.   Nature Communications

Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective

(2012) D. T. Le et al.   CANCER RESEARCH

Helper T cell diversity and plasticity

(2012) Shingo Nakayamada et al.   CURRENT OPINION IN IMMUNOLOGY

Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining ‘optimal’ residual disease

(2012) Suk-Joon Chang et al.   GYNECOLOGIC ONCOLOGY

BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis

(2012) Cécile Le Page et al.   PLoS One

Basic principles of tumor-associated regulatory T cell biology

(2012) Peter A. Savage et al.   TRENDS IN IMMUNOLOGY

Recent progress in the diagnosis and treatment of ovarian cancer

(2011) Danijela Jelovac et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Immunity and immune suppression in human ovarian cancer

(2011) Claudia C Preston et al.   Immunotherapy

Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer

(2011) J. Krempski et al.   JOURNAL OF IMMUNOLOGY

Inherited Determinants of Ovarian Cancer Survival

(2010) E. L. Goode et al.   CLINICAL CANCER RESEARCH

Ovarian Cancer Cells Induce Peripheral Mature Dendritic Cells to Differentiate Into Macrophagelike Cells In Vitro

(2010) Fangxue Chen et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Current Academic Clinical Trials in Ovarian Cancer

(2010) Edward L. Trimble et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel

(2010) P. Hoskins et al.   JNCI-Journal of the National Cancer Institute

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

(2010) Ellen L Goode et al.   NATURE GENETICS

Common variants at 19p13 are associated with susceptibility to ovarian cancer

(2010) Kelly L Bolton et al.   NATURE GENETICS

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

(2009) I. Kryczek et al.   BLOOD

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2

(2009) Honglin Song et al.   NATURE GENETICS

Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

(2008) E. Huarte et al.   CANCER RESEARCH